等待開盤 07-26 09:30:00 美东时间
+0.190
+0.67%
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1141651881139785729.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital:维持SurgePays Inc(SURG)"买入"评级,目标价从8.75美元升至9美元</p> <p>• Ascendiant Capital:维持LiqTech Internatio
06-17 09:46
Benchmark analyst Mark Palmer reiterates i3 Verticals (NASDAQ:IIIV) with a Buy and maintains $33 price target.
06-16 22:52
BitFuFu (NASDAQ:FUFU) will release its quarterly earnings report on Thursday, 2...
06-04 22:02
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行:维持Disc Medicine(IRON)"跑赢大市"评级,目标价从112美元升至120美元</p> <p>• 巴克莱:维持Karyopharm Therapeutics(KPTI)"超配"评级,目标价从5美
05-14 08:48
Morgan Stanley analyst James Faucette maintains i3 Verticals (NASDAQ:IIIV) with a Equal-Weight and lowers the price target from $27 to $25.
05-13 21:18
i3 Verticals (NASDAQ:IIIV) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of $0.30 by 6.67 percent. This is a 5.88 percent decrease over earnings of $0.34 per share from the same
05-09 05:59
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
The latest update is out from I3 Verticals ( ($IIIV) ). On May 5, 2025, i3 Vert...
05-06 21:16
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-12 22:56
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1096044530357866496.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行:维持Dakota Gold(DC)"跑赢大市"评级,目标价从6美元升至7.5美元</p> <p>• 杰富瑞:维持Compass Therapeutics(CMPX)"买入"评级,目标价从7美元升至8美元</p
02-11 18:08